When was Advanced Oncotherapy founded?

Advanced Oncotherapy was founded in 1994 and raised its 1st funding round 24 years after it was founded.

Where is Advanced Oncotherapy located?

Advanced Oncotherapy is headquartered in London, United Kingdom.

Who is the current CEO of Advanced Oncotherapy?

Nicolas Serandour of Advanced Oncotherapy.

How many employees does Advanced Oncotherapy have?

As of Jul 31, 2026, the latest employee count at Advanced Oncotherapy is 15.

Is Advanced Oncotherapy a funded company?

Advanced Oncotherapy is a funded company, having raised an undisclosed amount across 9 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on May 11, 2018.

When was the latest funding round of Advanced Oncotherapy?

Advanced Oncotherapy's latest funding was a $***** Post IPO round on Mar 20, 2023, with participation from 0 investor. Its primary sector is Oncology. In United Kingdom, the Oncology sector has seen $523M in funding in 2026 to date.

Where does Advanced Oncotherapy rank among its competitors?

Advanced Oncotherapy ranks 5th amongst 16 active competitors, of which 7 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Leo Cancer Care, which secured $65M in Jul, 2026.

Who are the top competitors of Advanced Oncotherapy?

Advanced Oncotherapy's top competitors include Varian Medical Systems, Leo Cancer Care and Terapet. Among them, Leo Cancer Care secured the most recent funding round in July, 2026.

Advanced Oncotherapy - 2026 Company Profile, Team, Funding, Competitors & Financials

Advanced Oncotherapy is a public company based in London (United Kingdom), founded in 1994. It operates as a Provider of proton beam therapy system for the treatment of cancer. Advanced Oncotherapy has raised an undisclosed amount in funding. The company has 16 active competitors, including 7 funded and 2 that have exited. Its top competitors include companies like Varian Medical Systems, Leo Cancer Care and Terapet.

Company Details

Advanced Oncotherapy has developed proton beam therapy systems for cancer treatment. The company's product LIGHT system uses a high-energy beam of protons to target tumors. The system is integrated with a proton source, radio-frequency quadrupole, nozzle system (dose delivery), low & high-speed accelerators, the patient positioning system, and the imaging system for targeting the tumors.

Website: avoplc.com
Social
Email ID: *****@avoplc.com
Phone Number: +44 **********

Key Metrics

Founded Year

1994

Location

London, United Kingdom

Stage

Public

Latest Funding Round

Post IPO, Mar 20, 2023, $*****

Investors

DNCA Finance & 2 more

Ranked

5^th among 16 active competitors

Employee Count

15 as on Jul 31, 2026

Investment & Acquisitions

Odey Asset Management

Similar Companies

Varian Medical Systems & 15 more

Exit Details

Public

View Advanced Oncotherapy's full profile

Advanced Oncotherapy is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ADVANCED ONCOTHERAPY PLC CIN: 5564418 , Germany, Active	Sep 14, 2005	-	157 (As on Dec 31, 2021)

Advanced Oncotherapy got listed on Jul 01, 2016.

Click here to take a look at Advanced Oncotherapy's IPO in detail

Advanced Oncotherapy has raised funding over 9 rounds. Its first funding round was on May 11, 2018. Advanced Oncotherapy has 3 institutional investors.

Here is the list of recent funding rounds of Advanced Oncotherapy:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2023	7284068	Post IPO	7160557	5396592	4701930	6976515
Apr 09, 2020	8665483	Post IPO	5577807	1214905	1983054	1503730
Nov 20, 2019	8290941	Post IPO	7788777	8509863	4366634	9536788

Access funding benchmarks and valuations. Sign up today!

View details of Advanced Oncotherapy's funding rounds and investors

Advanced Oncotherapy's employee count trend

Advanced Oncotherapy has 15 employees as of Jul 26. Here is Advanced Oncotherapy's employee count trend over the years:

Employee count trend for Advanced Oncotherapy

Uncover Advanced Oncotherapy's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Advanced Oncotherapy include Varian Medical Systems, Leo Cancer Care and Terapet. Here is the list of Top 10 competitors of Advanced Oncotherapy, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Varian Medical Systems 1948, Palo Alto (United States), Acquired	Provider and manufacturer of radiotherapy software and hardware solutions for professionals	-	Accelmed, BB Biotech Ventures & 2 others	61/100
2nd	Leo Cancer Care 2014, Crawley (United Kingdom), Series D	Manufacturer of upright patient positioning systems for radiation therapy treatments	$130M	WARF, Catalio Capital Management & 13 others	59/100
3rd	Terapet 2019, Geneva (Switzerland), Seed	Developer of integrated imaging solutions for proton therapy and nuclear medicine	$3.75M	Nina Capital, EFI Lake Geneva Ventures & 10 others	52/100
4th	P-Cure 2007, Lod (Israel), Series B	Imaging-based proton radiation therapy for cancer treatment	$30M	-	51/100
5th	Advanced Oncotherapy 1994, London (United Kingdom), Public	Provider of proton beam therapy system for the treatment of cancer	-	DNCA Finance, Aktiebolaget Segulah & 1 others	43/100
6th	HIL Medical 2010, Jerusalem (Israel), Series C	Developer of proton-beam radiotherapy device to treat solid tumors	$3.15M	EIC Fund, Europa & 3 others	38/100
7th	Provision Healthcare 2005, Knoxville (United States), Series B	Innovating cancer care with advanced proton therapy solutions and patient-centric approach	$30.4M	-	38/100
8th	B dot Medical 2017, Edogawa City (Japan), Series B	Developer of proton beam therapeutic devices for the treatment of cancer	$22M	Pegasus Tech Ventures, Mitsubishi UFJ Capital ... & 2 others	35/100
9th	Shanghai Aipqiang Particle Equipment 2012, Shanghai (China), Series A	Provider of proton therapy systems and related particle equipment	$6.29M	United Imaging Healthcare	29/100
10th	Proton Therapy Partners 2018, Wayne (United States), Funding Raised	Developer of proton therapy for treating cancer	-	Concord Health Partners	26/100